The United States has announced a trade agreement with the United Kingdom that eliminates tariffs on pharmaceutical products and medical technologies. In return, the United Kingdom will increase the percentage of the NHS budget allocated to medications and will pay 25% more for new drugs. The agreement aims to stimulate investment and innovation in both countries, according to U.S. Trade Representative Jamieson Greer. A change in the assessment of therapy value by NICE is also expected, which will modify the threshold used to determine the effectiveness of medications. The U.S. has pressured the UK to pay more for American drugs, and the pharmaceutical industry has expressed dissatisfaction with the conditions in the United Kingdom. London has committed to reducing the reimbursement rate to 15% starting in 2026.
Sources
Latest News
21:17
The two commercial vessels attacked by drones in Bulgaria’s Black Sea economic zone have been identified
21:11
Czech public television withdraws from Eurovision 2027 due to budget cuts
21:11
Norwegian Princess Märtha Louise and her husband are suing former close associates and seeking damages of more than $80 million
20:58
British student pleads guilty to murdering a Romanian woman, stabbed 78 times
20:56
Finland calls on Google to suspend work at two data centers pending an environmental impact assessment
See more news